- Business Wire•7 hours agoCelgene Announces Retirement of President and Chief Operating Officer, Jacqualyn Fouse, Ph.D. and Promotion of Scott Smith to President and Chief Operating Officer
Celgene Corporation today announced that President and Chief Operating Officer Jacqualyn Fouse, Ph.D., has decided to retire from Celgene effective June 30, 2017.
- Investopedia•8 hours ago
These 3 healthcare stocks began 2017 in an upward trend and may continue.
- Investopedia•9 hours ago
Revlimid was approved for multiple myeloma following autologous hematopoietic stem cell transplant.
CELG : Summary for Celgene Corporation - Yahoo Finance
Celgene Corporation (CELG)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||117.65 x 100|
|Ask||118.80 x 1000|
|Day's Range||117.70 - 119.95|
|52 Week Range||94.39 - 127.00|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||47.98|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|